Loading
PuraPharm Corporation Ltd. Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by CHAN YU LING, ABRAHAM, was filed 28 Oct 2025.
PuraPharm Corporation Ltd.: what insiders have been doing
PuraPharm Corporation Ltd. is a Health Care company. Its directors and officers file their transactions with HKEX. The last twelve months, up to 25 October 2026, brought 3 filings signed by 2 insiders.
Every open-market trade in the period is a purchase: 1 purchase worth €4,762, from 1 insider, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 senior executive. At €4,762, the purchase published on 28 October 2025 by Chan Yu Ling, Abraham is the largest of the period.
In all, 1 purchase was made within 30 days of a purchase by another insider of the company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The most recent open-market purchase was published on 28 October 2025, 362 days ago. Filings reach the HKEX feed a median of 5 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
With 3 filings in twelve months, the company is quieter than the median of 4 filings across the 1,315 companies we follow on the same exchange. Looking back to 2017, when coverage begins, insiders filed 79 purchases and 13 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Insider Decl.
190
Thresholds
n/a
Buy Volume
€22M
79 ops. · all time
Sell Volume
€6M
13 ops. · all time
Who traded when
BuySaleChan Yu Ling, Abraham2 buys1 sale
Since the insiders bought
- -43.3%Entry HK$0.42 · Close 23 Oct 2026 HK$0.24
- -9.6%Entry HK$0.83 · Close at T+365 HK$0.75
- -9.6%Entry HK$0.83 · Close at T+365 HK$0.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,488 of 26,317 companies
35.1
score / 100
Value44
Quality26
FCF yld20%
Earn yld-27%
EV/EBITDA15.6x
ROE-24%
Gross mgn54%
Net mgn-10%
Debt/EBITDA11.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$0.24
Analyst consensus
Income statement
RevenueHK$336.1M
Gross profitHK$180.2M54% margin
EBITDAHK$30.8M9% margin
Net income-HK$35.2M-8.6% margin
Valuation
P/Book1.0x
Beta0.24
Balance sheet & cash
Market capHK$128.4M
Total debtHK$351.1M
Free Cash FlowHK$25.7M
Debt / Equity297%
Profitability & ownership
ROE-24.4%
ROA-0.7%
% insiders65.3%
% institutions0.0%
Last declaration on 11 May 2026
Declarations190 total
110,500 sharesShareXHKGHKEX:DA20260508E00567
93,488,372 shares@ HK$0.4318.2% of flowShareXHKGHKEX:DA20251104E00341
93,488,372 shares@ HK$0.4318.5% of flowShareXHKGHKEX:DA20251104E00345
100,000 shares@ HK$0.430.0% of flowShareXHKGHKEX:DA20251028E00490
Canonical exit: 21 Jan 2026 (T+90)
100,000 shares@ HK$0.430.0% of flowShareXHKGHKEX:DA20251028E00491
Canonical exit: 21 Jan 2026 (T+90)
93,488,372 shares@ HK$0.4317.8% of flowShareXHKGHKEX:DA20250730E00432
Canonical exit: 23 Oct 2025 (T+90)
93,488,372 shares@ HK$0.4318.0% of flowShareXHKGHKEX:DA20250730E00434
Canonical exit: 23 Oct 2025 (T+90)
1,000,000 shares@ HK$0.500.2% of flowShareXHKGHKEX:DA20250702E00299
1,000,000 shares@ HK$0.500.2% of flowShareXHKGHKEX:DA20250702E00300
20,000 shares@ HK$1.090.0% of flowShareXHKGHKEX:DA20230424E00168
Canonical exit: 19 Jul 2023 (T+90)
20,000 shares@ HK$1.090.0% of flowShareXHKGHKEX:DA20230424E00170
Canonical exit: 19 Jul 2023 (T+90)
3,850,000 sharesShareXHKGHKEX:DA20230103E00374
Canonical exit: 29 Mar 2023 (T+90)
3,850,000 sharesShareXHKGHKEX:DA20230103E00373
Canonical exit: 29 Mar 2023 (T+90)
3,850,000 sharesShareXHKGHKEX:DA20230103E00372
Canonical exit: 29 Mar 2023 (T+90)
3,850,000 sharesShareXHKGHKEX:DA20230103E00375
Canonical exit: 29 Mar 2023 (T+90)
30,000 shares@ HK$1.420.0% of flowShareXHKGHKEX:DA20220727E00510
Canonical exit: 25 Oct 2022 (T+90)
30,000 shares@ HK$1.420.0% of flowShareXHKGHKEX:DA20220727E00511
Canonical exit: 25 Oct 2022 (T+90)
77,500 shares@ HK$1.52650.1% of flowShareXHKGHKEX:DA20220505E00424
Canonical exit: 1 Aug 2022 (T+90)
77,500 shares@ HK$1.52650.1% of flowShareXHKGHKEX:DA20220505E00426
Canonical exit: 1 Aug 2022 (T+90)
4,146,665 sharesShareXHKGHKEX:DA20220406E00073
100,000 shares@ HK$0.860.0% of flowShareXHKGHKEX:DA20211020E00285
Canonical exit: 13 Jan 2022 (T+90)
100,000 shares@ HK$0.860.0% of flowShareXHKGHKEX:DA20211020E00289
Canonical exit: 13 Jan 2022 (T+90)
333,335 sharesShareXHKGHKEX:DA20210630E00447
60,000 sharesShareXHKGHKEX:DA20210617E00355
4,000 sharesShareXHKGHKEX:DA20210617E00364
25 of 190 declarations
About PuraPharm Corporation Ltd.
PuraPharm Corporation Ltd. is a company focused on the health and pharmaceutical sector, providing products and services related to traditional Chinese medicine. It is listed on the Hong Kong Stock Exchange (XHKG).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
